Atlas FDA

Mynx Control Vascular Control Device (5F, 6F/7F)

FDA premarket approval P040044/S094 · decided 2023-07-13

Approval details

PMA number
P040044
Supplement
S094
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
Mynx Control Vascular Control Device (5F, 6F/7F)
Generic name
Device, hemostasis, vascular
Applicant
Cordis US Corporation
Date received
2023-04-17
Decision date
2023-07-13
Days to decision
87 days
Decision code
APPR
Product code
MGB
Advisory committee
Cardiovascular
Expedited review
No
Location
Miami Lakes, FL
Statement
Approval for minor design and material modifications to the deployment button on the Mynx Control Vascular Closure Devices.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.